Skip Content
You are currently on the new version of our website. Access the old version .
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Current Oncology, Volume 13, Issue 6

2006 December - 6 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (6)

  • Article
  • Open Access
11 Citations
860 Views
6 Pages

Recommendations of the Canadian Consensus Group on the Management of Chronic Myeloid Leukemia

  • P. Laneuville,
  • M.J. Barnett,
  • R. Bélanger,
  • S. Couban,
  • D.L. Forrest,
  • D.C. Roy and
  • J.H. Lipton

1 December 2006

Chronic myelogenous leukemia (CML) is a disease characterized by the expression of Bcr/Abl, an oncogenic protein tyrosine kinase, and by evolution over time from a relatively benign chronic phase to a rapidly fatal CML blast crisis. Until recently, t...

  • Article
  • Open Access
44 Citations
1,156 Views
8 Pages

The Use of Prophylactic Anticonvulsants in Patients with Brain Tumours—A Systematic Review

  • J. Perry,
  • L. Zinman,
  • A. Chambers,
  • K. Spithoff,
  • N. Lloyd,
  • N. Laperriere and
  • on behalf of the Neuro-oncology Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care

1 December 2006

Questions: Should patients with newly diagnosed brain tumours receive prophylactic anticonvulsants to reduce seizure risk? What is the best practice for patients with brain tumours who are taking anticonvulsant medications but who have never had a se...

  • Article
  • Open Access
7 Citations
654 Views
8 Pages

1 December 2006

The value of radiotherapy for palliation is well known to oncologists but not necessarily to other physicians. Using terms such as symptom improvement ratio (SIR) and number needed to treat (NNT) rather than traditional response rates might be more a...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729